PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Psychiatr Res. Author manuscript; available in PMC 2014 May 1.
Published in final edited form as:
PMCID: PMC3594625
NIHMSID: NIHMS437590

Association of elevated cytokines with childhood adversity in a sample of healthy adults

Karen J. Hartwell, M.D.,1,2 Megan M. Moran-Santa Maria, Ph.D.,1 Waleed O. Twal, Ph.D.,3 Stephanie Shaftman, MSc., MS.,4 Stacia M. DeSantis, Ph.D.,4 Aimee L. McRae-Clark, Pharm. D.,1 and Kathleen T. Brady, M.D., Ph.D.1,2

Abstract

Objective

Childhood trauma has been associated adult stress-related disorders. However, little is known about physiologic alterations in adults with a history of early life trauma that do not have current psychiatric or medical diagnoses. In this study, the relationships between childhood adversity and cytokine and C - reactive protein (CRP) levels in healthy adults were examined.

Method

Participants included men (n=18) and women (n=20) who did not meet DSM-IV criteria for Axis I psychiatric disorders or any major medical illness. Cytokine and CRP levels were obtained from baseline blood samples. Subjects completed the Early Trauma Inventory Self Report (ETI-SR). The primary outcomes included serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-1β (IL1-β), and CRP levels. In addition, the mean numbers of traumatic experiences (sexual, physical, emotional, general, and the summed total) were measured.

Results

Significant positive associations were found between the total ETI score and IL-6 (p = 0.05), IL1-β (p < 0.05), and TNF-α (p = 0.01). Significant positive correlations were found between the number of general traumas and IL1-β (p < 0.05), TNF-α (p < 0.05), and IL-6 (p < 0.01). Neither the total number of traumas nor any of the trauma subscales were significantly associated with CRP levels.

Conclusions

The positive association between childhood trauma and basal cytokine levels supports the extant literature demonstrating the long-term impact of childhood trauma and stress on homeostatic systems. Importantly, this association was found in healthy adults, suggesting that these alterations may precede the development of significant stress-related psychiatric disorder or disease.

Keywords: life stress, biological stress, innate immunity, cytokines, C-reactive protein

Introduction

The association between early life stress and stress-related psychiatric disorders is well documented (Dube et al., 2001; Felitti et al., 1998; Mullen, Martin, Anderson, Romans, & Herbison, 1996). For example, exposure to childhood adversity and stress increases the risk for the development of depression and post traumatic stress disorder during adulthood (PTSD) (Chapman et al., 2004; Felitti et al., 1998; Widom, 1999). Despite these findings, the mechanistic connection between childhood adversity and stress-related psychiatric disorders is not well-delineated. However, an emerging literature suggests that prolonged and persistent pro-inflammatory signaling may play a role in the pathophysiology of stress related disorders in adults.

The cytokines interleukin-6 (IL-6), interleukin-1beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) the acute phase protein c-reactive protein (CRP) mediate the acute inflammatory response to psychological stress (Steptoe, Hamer, & Chida, 2007). Immobilization or open field exposure increases plasma levels of IL-6 in rodents (LeMay, Vander, & Kluger, 1990; Zhou, Kusnecov, Shurin, DePaoli, & Rabin, 1993). Clinical studies have found that cognitive and psychosocial stress tasks increase plasma CRP (Hamer et al., 2006b), TNF-α, IL-1β (Altemus, Rao, Dhabhar, Ding, & Granstein, 2001) and IL-6 (Brydon et al., 2005; Maes et al., 1998) levels. The change in mononuclear IL-1β gene expression was positively correlated with plasma IL-6 levels, subjective stress and anxiety (Brydon et al., 2005). Similarly, Maes and colleagues found that students with the highest subjective stress response to an academic exam exhibited significantly higher stimulated IL-6 and TNF-α levels than students with low subjective stress (Maes et al., 1998). Importantly, IL-6 and CRP fail to habituate to repeated psychosocial stress and are elevated in individuals exposed to chronic stress (Alley et al., 2006; Hamer, Gibson, Vuononvirta, Williams, & Steptoe, 2006a; Kiecolt-Glaser et al., 2003; von Kanel, Kudielka, Preckel, Hanebuth, & Fischer, 2006). A convergence of evidence suggests that prolonged pro-inflammatory signaling is a critical component of the pathophysiology underscoring stress-related psychiatric disorders (Maes et al., 1999; Straub, 2006).

Functional alterations in limbic brain regions have been associated with symptoms of stress and anxiety disorders. Cytokines increase noradrenergic transmission to limbic brain regions which may underscore the altered limbic tone that has been linked with hyperarousal in PTSD (Shin et al., 2005; Zalcman et al., 1994). In addition, central administration of an IL-1 receptor antagonist attenuated c-fos expression in the amygdala and reduced depressive-like behaviors to bacterial lipopolysaccharide (LPS) challenge (Konsman et al., 2008). Elevated basal and LPS stimulated cytokine and CRP levels in individuals with PTSD (Baker et al., 2001; Gill, Vythilingam, & Page, 2008; Spitzer et al., 2010; Spivak et al., 1997), depression (Himmerich et al., 2008; Howren, Lamkin, & Suls, 2009; Maes, Twisk, & Ringel, 2012) and myalgic encephalomyelitis (ME/cfs) (Fletcher, Zeng, Barnes, Levis, & Klimas, 2009). Plasma cytokine levels were significantly greater in individuals with comorbid depression and ME/cfs than in individuals with depression alone (Maes et al., 2012). Of note, individuals with depression, PTSD or comorbid depression and PTSD exhibited significantly greater serum IL-6 and soluble IL-6 receptor (sIL-6R) levels than healthy controls suggesting that elevated pro-inflammatory cytokine signaling plays a critical role in the pathophysiology of stress-related psychiatric disorders (Maes et al., 1999; Maes et al., 1995; Sluzewska et al., 1996). Despite these findings, the role of cytokines and CRP in mediating risk for the development of stress and anxiety disorders as a consequence of childhood abuse and maltreatment is unclear.

A prospective study demonstrated that maltreated children are at risk for developing clinically relevant CRP levels (Danese, Pariante, Caspi, Taylor, & Poulton, 2007). Unfortunately, the prevalence of PTSD among study participants was not measured and therefore it is difficult to discern whether the CRP levels were a function of childhood maltreatment or PTSD. Elevated CRP levels have also been found in adults who were raised in harsh family environments and low childhood socioeconomic status (Taylor, Lehman, Kiefe, & Seeman, 2006). However, CRP levels were also associated with BMI and psychosocial dysfunction. Another study found that healthy adults with a history of childhood trauma exhibited greater IL-6 levels in response to a psychosocial stressor than healthy adults without a history of childhood trauma (Carpenter et al., 2010). Thus, childhood trauma may indeed be linked to long-term dysregulation in the IL-6 response to acute stress. Given the reciprocal and dynamic relationship between IL-6, TNF-α, IL-1β and CRP, understanding the impact of childhood trauma on multiple cytokines may provide addition insight into the pathophysiology of psychiatric disorders. To our knowledge surprisingly little is known about TNF-α and IL1-β levels in healthy adults with a history of childhood maltreatment.

The objective of this study was to examine the impact of exposure to adverse events during childhood on basal cytokine and CRP levels in a cohort of healthy adult subjects free of current psychiatric and medical illness. We hypothesized that healthy subjects exposed to more adversity during childhood would have significantly greater IL-1β, IL-6, TNF-α, and CRP levels as compared to those without exposure to significant adversity during childhood.

Materials and Methods

Subjects

This secondary analysis was conducted from a larger study on gender differences in stress response among individuals with and without cocaine-dependence. These data have been presented in separate manuscripts (Brady et al., 2009; Waldrop et al., 2010). Only non cocaine-dependent healthy control subjects were included in the present analysis. Plasma was missing from seven control participants, thus these individuals were not included in the present analysis. The analysis was conducted using data from 38 healthy controls. Subjects were recruited from a 50-mile radius of the Charleston area, via media advertisements over a 48-month period. All procedures were conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki, and received Institutional Review Board approval. Informed consent was acquired prior to study participation. General exclusion criteria included (1) current major depressive disorder (MDD) (2) current post traumatic stress disorder (PTSD); (3) current or lifetime history of other major Axis I disorders such as bipolar disorder, schizophrenia, somatoform disorder, etc. (4) history of or current medical conditions that might interfere with safe conduct of the study or impact HPA activity, including ischemic heart disease, chronic obstructive pulmonary disease, ME/cfs, fibromyalgia, endocrine and autoimmune disorders; (5) history of or current psychotic, eating, or bipolar affective disorders; (6) synthetic glucocorticoid steroid therapy within one month of testing; (7) current benzodiazepine, antidepressant, antipsychotic, beta-blocker and other medication use that might interfere with HPA axis activity or psychophysiologic measurement; (8) pregnancy, nursing, or ineffective means of birth control; (9) body mass index ≥ 35; or (10) DSM-IV criteria for substance dependence except caffeine, nicotine or marijuana within the past 60 days. Study procedures were conducted at the Clinical and Translational Research Center (CTRC) of the Medical University of South Carolina. Subjects meeting inclusion criteria and failing to meet exclusion criteria were admitted to an inpatient unit at approximately 2000 hr the evening prior to testing. Subjects were rescheduled if there was any indication of acute infection or injury. Subjects dependent on nicotine were provided with a nicotine patch.

Plasma Cytokine Analysis

Blood samples were drawn from each participant at 1640 hr. which was 20 minutes prior to a corticotropin releasing hormone challenge. Blood was collected in EDTA-prepared tubes and immediately placed on ice. Plasma was obtained by centrifugation under refrigeration and the sample frozen at −70° C until assayed in duplicate. Measurements of cytokine levels were done using multiplex bead-array kit from Affymetrix according to manufacturer instructions with few modifications. A total of 16 assays (n=8 plates CRP; n=8 plates cytokines) were run by the same operator who was blinded to the data. Samples were run undiluted for IL-6, TNF-α and IL1-β and at 1:1000 dilution for CRP. Beads were incubated with the samples (50 µl, diluted 1:1 in assay buffer) for 60 minutes and then rinsed and incubated with detection biotinylated antibody and phycoerythrin-conjugated strepavidin. Detection was done using a BioRad Bio-Plex 200 machine. Each cytokine level was compared to a standard curve supplied in the kit. The inter-assay variability (% CV) were 10, 5.5, 5.5 and 16% for CRP, IL1-β, IL-6 and TNF-α respectively. Limits of detection (pg/ml) were 2.2–40,000, 0.2–516, 1.7–16,058 and 0.2–1.0 for CRP, IL1-β, IL-6 and TNF-α respectively. Cross reactivity was less than 5%.

Assessment

Subjects were screened prior to study participation with a physical exam, blood chemistry panel, and EKG. Physical health, prescription and over the counter medication and supplement use were reviewed by the clinician. Each subject was asked to fill-out the Early Trauma Inventory (ETI) (Bremner, Vermetten, & Mazure, 2000). The ETI is a 56-item self-report form which is used to evaluate early life trauma, including physical, sexual, emotional, and general forms of trauma. The ETI assesses the number, frequency, duration, and subjective impact (i.e., functional, emotional and relational) of traumatic experiences. The appropriate items endorsed were summed to create five variables of interest: total number of traumas, physical, emotional, sexual, and general traumas. The general trauma subscale consists of 21 items including questions such as exposure to natural disasters, serious personal injury or illness, parental separation, death of loved one, exposure to domestic violence, assault, combat etc. Experiences such as slaps in the face, burns, and choking are included in the 9-item physical trauma subscale. The 7-item emotional trauma subscale reflects experiences of ridicule, verbal abuse, and emotional neglect. The sexual trauma subscale includes 15 questions varying from inappropriate comments about sex or sexual parts to rape. High test-retest reliability, internal consistency, and external validity have been reported for the ETI (Bremner et al., 2000).

Stress and anxiety ratings were obtained at baseline using a modified Distress/Mood Scale, (Childress, McLellan, & O'Brien, 1986). This 100-mm visual 10-point Likert scale is anchored with adjectival modifiers (0) “not at all” to (10) “extremely”.

Statistical Analysis

The primary hypothesis was that the total number of adverse events endorsed on the ETI would positively correlate with baseline blood plasma cytokine concentration. To test this hypothesis, a linear regression model was fit with the log of the baseline cytokine as the outcome and total number of traumas as the predictor. Covariates controlled for in regression analysis included smoking status, gender, and the interaction between gender and the total number of traumas. If the interaction was insignificant, it was removed from the model. Secondary analysis considered trauma subscales - number of physical, sexual, emotional, and general traumas as predictors of baseline cytokine levels, also controlling for covariates. Separate regression models were fit for each trauma subscale and the analytic procedure was the same as for the primary outcome. Residual analysis indicated violations of normality, and a log transformation of cytokines was necessary. Results are presented in terms of type III sums of squares F-tests, degrees of freedom, and associated p-values. Results concerning demographic and potential confounding variables are presented in terms of means and standard errors (SE). Type I error rate was set at alpha = 0.05. Bonferonni adjusted alpha was set at 0.0125 for trauma subscales listed in Table 2. All analyses were performed in SAS (SAS/STAT software, Version 9.1.3, SAS Institute Inc., Cary, NC, USA).

Table 2
Comparison of trauma subtype with cytokine and CRP levels

Results

Demographic and trauma characteristics of the sample are displayed in Table 1. All of the participants were in general good health. The most commonly listed minor medical problem was seasonal allergies (n=4). Occasional use of ibuprofen or similar non-steroidal anti-inflammatory drugs was reported by four individuals. No one reported taking an antioxidant, omega-3, statin, or other medications and supplements expected to alter the inflammatory system. The mean (SE) number of general, sexual, physical, and emotional traumas reported by the group was 6.4 (0.9), 1.6 (0.5), 2.8 (0.33) and (0.42) respectively. One female reported 21 childhood traumas and statistically confirmed to be an outlier. Data from this subject was removed from subsequent analyses. The mean level of IL-6, IL1-β, TNF-α, and CRP were 1.74, 0.70, 4.10, and 711.5 pg/ml respectively. There were no differences in gender or age between people reporting exposure to traumatic experiences (n=35) and those who did not (n=4). The percentage of participants with a past history of depression was 21.1%. Five participants of the participants rated their stress and anxiety levels above zero. Within these individuals stress scores ranged from one (lowest) to four (highest) and anxiety scores ranged from one (lowest rating) to five (highest rating). Plasma levels of IL-6, TNF-α, IL-1β and CRP in the individual with the highest stress and anxiety scores were 1.13, 0.07, 1.74 and 254.3 pg/ml respectively.

Table 1
Study Demographics

IL-6

The adjusted regression model indicated the total number of traumas was associated with IL-6 levels (F1,30 = 4.05; p = 0.05) (Figure 1A). When trauma subscales were considered, there was a significant and positive relationship between the number of general traumas and IL-6 levels (F1,30 = 13.65, p <0.01) (Table 2).

Figure 1
Comparison of basal cytokine levels and total ETI score in healthy control subjects. (A) IL-6 (B) IL1-β (C) TNF-α (D) CRP. The sum of ETI items endorsed in each of the four domains (sexual, physical, emotional, and general trauma) was ...

IL1-β

The adjusted regression model indicated that the total number of traumas was positively and significantly associated with IL1-β levels (F1,29 = 5.24; p < 0.05) (Figure 1B). When trauma subscales were considered, the number of general traumas was found to be independently associated with IL1-β levels (F1,29 = 6.04; p < 0.05) (Table 2). However, when the data were analyzed using a Bonferonni adjusted α=0.0125, there was no association between general trauma and basal IL1-β.

TNF-α

The adjusted regression model indicated the total number of traumas was associated with TNF-α (F1,25 = 7.86; p = 0.01) (Figure 1C). When trauma subscales were considered, the number of general traumas found to be independently associated with TNF-α (F1,25 = 5.47; p < 0.05) (Table 2). However, when the data were analyzed using a Bonferonni adjusted α=0.0125, there was no association between general trauma and basal TNF-α.

CRP

The adjusted regression model indicated the total number of traumas was not significantly associated with CRP (p > 0.05) (Figure 1D). When trauma subscales were considered, the number of emotional traumas was found to be independently associated with CRP (F1,30 = 4.42, p =0.04) (Table 2). However, when the data were analyzed using a Bonferonni adjusted α=0.0125, there was no association between emotional trauma and CRP.

Discussion

Studies of individuals with a significant history of adverse childhood experiences and stress-related psychiatric disorders have demonstrated dysregulation in neurobiologic systems, but it is difficult to determine if this dysregulation is involved in the connection between childhood adversity and the adult disorder or is simply a manifestation of the disorder (Heim & Nemeroff, 2001a; Heim, Newport, Bonsall, Miller, & Nemeroff, 2001b). In the present study, a significant and positive relationship was found between childhood trauma and basal IL-6, TNF-α, and IL-1β levels in healthy adults who were free of any significant psychiatric and medical illness. The percentage of participants with a past history of depression was 21.1% and consistent with the lifetime prevalence rates of depression for adults aged 30–44 reported in the National Comorbidity Study (Kessler et al., 2005). In addition, no one met criteria for current or past PTSD or any psychiatric disorder and participants were free of anti-inflammatory medications and supplements that would alter pro-inflammatory cytokine levels. In this regard, the discovery of a significant and positive relationship between pro-inflammatory cytokine levels and childhood adversity in a healthy group of adults provides some insight into a potential biologic mechanism through which childhood adversity may be connected to stress-related psychiatric disorders in adulthood.

Data from developmental neuroscience studies suggest that early life stress may program an organism’s sensitivity to subsequent stress throughout the lifespan (Ladd et al., 2000; Meaney, 2001). The finding of a significant positive association between early life stress and basal cytokine levels is consistent with the literature. For example, healthy adults with a history of early life stress exhibited altered HPA axis hormonal responses to laboratory stress tasks (Heim et al., 2001b; Heim et al., 2000; Moran-Santa Maria et al., 2010). In addition, early life stress has been associated with a reduction in hippocampal volume and a sensitized amygdala response to aversive social cues (Dannlowski et al., 2012). Interestingly, a growing literature suggests that over expression and amplification of the innate inflammatory response to acute stress plays a critical role in the pathophysiology of psychiatric disorders (Leonard & Maes, 2012). Sensitized noradrenergic tone in limbic brain regions has been implicated stressassociated psychiatric disorders (Bloom, 1995). Stress and norepinephrine stimulate cytokine production in limbic brain regions (Hueston et al., 2011; Johnson et al., 2008; Nguyen et al., 1998). Moreover, pro-inflammatory cytokines levels fail to habituate to repeated stress exposure (Porterfield, Gabella, Simmons, & Johnson, 2012; von Kanel et al., 2006). Preclinical studies have found that prolonged and elevated pro-inflammatory signaling attenuates neurogenesis, exacerbates oxidative and nitrosative stress pathways, promotes glutamatergic excitotoxicity and hippocampal neurodegeneration; cellular mechanisms that have been implicated in symptoms of depression and anxiety disorders (Duman & Monteggia, 2006; Tilleux & Hermans, 2007; Viviani et al., 2006; Wang et al., 2012; Zou & Crews, 2005). In addition, data from both clinical and preclinical studies have linked elevated cytokine levels with symptoms of depression and anxiety disorders. For example, exogenous IL-6 administration in limbic brain regions increases anxiety-like behaviors in rodents (Wu & Lin, 2008). Basal cerebrospinal fluid levels of cytokines were positively associated with the clinical severity of depression (Martinez, Garakani, Yehuda, & Gorman, 2012).

The present findings may have significant implications for stress-associated medical disorders. For example, cytokines have been implicated in the pathophysiology of chronic inflammatory disorders (Boekholdt et al., 2006; Danesh et al., 2008; Popivanova et al., 2008; Saxne, Palladino, Heinegard, Talal, & Wollheim, 1988). Childhood maltreatment and abuse are associated with an elevated risk for cancer, autoimmune disorders, cardiovascular and chronic obstructive pulmonary diseases (Anda et al., 2008; Dube et al., 2009; Felitti et al., 1998). Of note, the prevalence of depression and anxiety disorders among individuals with chronic inflammatory diseases is high and suggests that stress-associated psychiatric disorders and inflammatory diseases share a common pathophysiology (Chapman, Perry, & Strine, 2005). For example, elevated levels of TNF-α have been found in individuals with a history of myocardial infarction (MI), and there is a high prevalence of depression among MI patients (Halaris, 2009; Odeh, 1993; Ziegelstein, 2001). In addition, plasma levels of IL-6, TNF-α, IL-1 were significantly greater in individuals with comorbid depression and ME/cfs than in individuals with depression alone (Maes et al., 2012). Thus, prolonged pro-inflammatory signaling as a result of early life stress may play a critical role in the risk for the development of stress-associated psychiatric and inflammatory disorders. This connection is clearly speculative and longitudinal assessment of biomarkers is necessary.

While the strength of the relationship between cytokines and childhood adversity varied depending on the cytokine and the type of adverse event, the relationship was consistently in a positive direction. The total trauma score has the largest number of items and therefore the greatest statistical power. Significant associations were found between all three cytokines and general trauma. The association between IL-6 and general trauma remained significant after adjusting for multiple tests. Although the adjusted analysis failed to find significant associations between IL-1β, TNF-α, and general trauma, a similar positive trend was observed indicating that general trauma may be a significant mediator of adult cytokine levels. The general trauma subscale contains a substantially larger number of items than the other scales (21 vs. 15, 9 and 7). Therefore, the positive association between the number of general traumas and IL1-β, TNF-α and IL-6 may partly reflect the greater statistical power of this subscale. Additionally some items within the general trauma subscale are common occurrences. For example, as no-fault divorce laws were enacted, divorce rates rapidly climbed during the 1970s and early 1980s when the majority of the sample were children.

There was no association between emotional abuse and basal cytokine levels. The finding of an inverse association between plasma CRP levels and emotional trauma was insignificant after adjusting for multiple tests. Previous studies have linked early emotional abuse and neglect with dysregulation in the oxytocin system (Fries, Shirtcliff, & Pollak, 2008; Heim et al., 2009; Meinlschmidt & Heim, 2007). Thus, early emotional abuse and neglect may trigger a cascade of physiologic events that are independent of pro-inflammatory signaling.

Intuitively, one might expect sexual and physical traumas to be among the most severe trauma types and therefore most likely to be positively associated with long-term sequelae. However, the number of possible items to be endorsed on both of these subscales was small, limiting the statistical power of these analyses. In addition, the sexual trauma items on the ETI are heterogeneous and include items such as inappropriate sexual comments which are weighted as heavily as the “completed rape” item. Moreover childhood physical and sexual abuse is commonly under-reported even in self-reported surveys. Therefore, subjects may have been reluctant to disclose a history of victimization.

Income and education exhibit strong associations with health outcomes including health behaviors, morbidity, and mortality (Kawachi, Adler, & Dow, 2010). Taylor and colleagues found a positive association between low childhood socioeconomic status (SES) and CRP levels mitigated through BMI and psychosocial dysfunction (Taylor et al., 2006). In the present study, childhood adversity was not associated with adult CRP levels. However, our study participants were free of psychosocial dysfunction which may explain the disparate findings. A recent study found that childhood adversity was positively associated with several inflammatory markers in African Americans (Slopen et al., 2010). In contrast to our study, Slopen’s (2010) study included subjects who had a history of diabetes and cardiovascular disease and medications which may alter basal cytokine levels. In support of the present findings, no association was found between plasma CRP levels and childhood adversity in healthy adults (Carpenter, Gawuga, Tyrka, & Price, 2012).

There are a number of study limitations. Information impacting the inflammatory system such as sleep and exercise were not carefully assessed and may have influenced the cytokines levels. While the highest level of education obtained and employment serve as a rough proxy for current socioeconomic status (SES), information about childhood SES was not collected. As a result the impact of this childhood SES could not be included as a covariate in the statistical analysis. It is important to note however, that we did find an association between three cytokines and childhood trauma in a population of adults that appear to be in a higher SES. Although current SES data were not directly collected in the present study, 30 (77%) of the subjects were employed and 32 (84%) reported “some” college education. These findings are indeed intriguing and suggest that the impact of childhood trauma leaves a long-term physiological footprint that remains independent of adult socioeconomic status. Maes and colleagues found a significant association between perceived stress and stimulated cytokine levels (Maes et al., 1998). In the present study, only five of the 38 participants rated their stress or anxiety levels above zero. In addition, plasma IL-6 and TNF-α levels from the participant with the highest stress and anxiety ratings were below the group mean. Thus, it is unlikely that basal cytokine levels measured in the present study were due to stress or anxiety associated with anticipation of the task. In this preliminary investigation, the study may be statistically underpowered due to the small sample size. Thus similar studies with larger sample sizes are warranted. Similar studies assessing other biomarkers of inflammation and cellular immunity including plasma haptoglobin, neopterin and anti-cytokine levels may provide a more comprehensive understanding of the scale of immune system dysregulation. In addition, given the evidence supporting sensitization of pro-inflammatory cytokine signaling in the pathophysiology of stress-associated disorders, studies assessing soluble IL-6, IL-1 and TNF receptor levels and cellular markers of oxidative and nitrosative stress may provide critical insight into the mechanistic link between childhood adversity and stress-related disorders in adults.

In conclusion, this is the first study to our knowledge to demonstrate a significant positive association between childhood adversity and basal cytokine levels. This association is consistent with the extant literature supporting long-term adaptations in homeostatic systems as a consequence of childhood stress and adversity. Moreover, these findings may have important health implications both in terms of understanding disease process and the nature of resilience.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun. 2006;20:498–504. [PubMed]
  • Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117:309–317. [PubMed]
  • Anda RF, Brown DW, Dube SR, Bremner JD, Felitti VJ, Giles WH. Adverse childhood experiences and chronic obstructive pulmonary disease in adults. Am J Prev Med. 2008;34:396–403. [PubMed]
  • Baker DG, Ekhator NN, Kasckow JW, Hill KK, Zoumakis E, Dashevsky BA, Chrousos GP, Geracioti TD., Jr Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation. 2001;9:209–217. [PubMed]
  • Bloom FE, Kupfer DJ. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press Ltd; 1995. Recent studies on norepinephrine systems in mood disorders.
  • Boekholdt SM, Hack CE, Sandhu MS, Luben R, Bingham SA, Wareham NJ, Peters RJ, Jukema JW, Day NE, Kastelein JJ, Khaw KT. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993–2003. Atherosclerosis. 2006;187:415–422. [PubMed]
  • Brady KT, McRae AL, Moran-Santa Maria MM, DeSantis SM, Simpson AN, Waldrop AE, Back SE, Kreek MJ. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch Gen Psychiatry. 2009;66:422–430. [PMC free article] [PubMed]
  • Bremner JD, Vermetten E, Mazure CM. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress Anxiety. 2000;12:1–12. [PubMed]
  • Brydon L, Edwards S, Jia H, Mohamed-Ali V, Zachary I, Martin JF, Steptoe A. Psychological stress activates interleukin-1beta gene expression in human mononuclear cells. Brain Behav Immun. 2005;19:540–546. [PubMed]
  • Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology. 2010;35:2617–2623. [PMC free article] [PubMed]
  • Carpenter LL, Gawuga CE, Tyrka AR, Price LH. C-reactive protein, early life stress, and wellbeing in healthy adults. Acta Psychiatr Scand. 2012;126:402–410. [PMC free article] [PubMed]
  • Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis. 2005;2:A14. [PMC free article] [PubMed]
  • Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord. 2004;82:217–225. [PubMed]
  • Childress AR, McLellan AT, O'Brien CP. Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings. J Subst Abuse Treat. 1986;3:173–179. [PubMed]
  • Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A. 2007;104:1319–1324. [PubMed]
  • Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78. [PMC free article] [PubMed]
  • Dannlowski U, Stuhrmann A, Beutelmann V, Zwanzger P, Lenzen T, Grotegerd D, Domschke K, Hohoff C, Ohrmann P, Bauer J, Lindner C, Postert C, Konrad C, Arolt V, Heindel W, Suslow T, Kugel H. Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry. 2012;71:286–293. [PubMed]
  • Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, Giles WH. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA. 2001;286:3089–3096. [PubMed]
  • Dube SR, Fairweather D, Pearson WS, Felitti VJ, Anda RF, Croft JB. Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med. 2009;71:243–250. [PMC free article] [PubMed]
  • Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59:1116–1127. [PubMed]
  • Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14:245–258. [PubMed]
  • Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96. [PMC free article] [PubMed]
  • Fries AB, Shirtcliff EA, Pollak SD. Neuroendocrine dysregulation following early social deprivation in children. Dev Psychobiol. 2008;50:588–599. [PMC free article] [PubMed]
  • Gill J, Vythilingam M, Page GG. Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD. J Trauma Stress. 2008;21:530–539. [PMC free article] [PubMed]
  • Halaris A. Comorbidity between depression and cardiovascular disease. Int Angiol. 2009;28:92–99. [PubMed]
  • Hamer M, Gibson EL, Vuononvirta R, Williams E, Steptoe A. Inflammatory and hemostatic responses to repeated mental stress: individual stability and habituation over time. Brain Behav Immun. 2006a;20:456–459. [PubMed]
  • Hamer M, Williams E, Vuonovirta R, Giacobazzi P, Gibson EL, Steptoe A. The effects of effort-reward imbalance on inflammatory and cardiovascular responses to mental stress. Psychosom Med. 2006b;68:408–413. [PubMed]
  • Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001a;49:1023–1039. [PubMed]
  • Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001b;158:575–581. [PubMed]
  • Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284:592–597. [PubMed]
  • Heim C, Young LJ, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry. 2009;14:954–958. [PubMed]
  • Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Kloiber S, Lucae S, Ising M, Uhr M, Holsboer F, Pollmacher T. Depression, comorbidities and the TNF-alpha system. Eur Psychiatry. 2008;23:421–429. [PubMed]
  • Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–186. [PubMed]
  • Hueston CM, Barnum CJ, Eberle JA, Ferraioli FJ, Buck HM, Deak T. Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat. Physiol Behav. 2011;104:187–198. [PubMed]
  • Johnson JD, Cortez V, Kennedy SL, Foley TE, Hanson H, 3rd, Fleshner M. Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge. Brain Behav Immun. 2008;22:1078–1086. [PMC free article] [PubMed]
  • Kawachi I, Adler NE, Dow WH. Money, schooling, and health: Mechanisms and causal evidence. Ann N Y Acad Sci. 2010;1186:56–68. [PubMed]
  • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. [PubMed]
  • Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A. 2003;100:9090–9095. [PubMed]
  • Konsman JP, Veeneman J, Combe C, Poole S, Luheshi GN, Dantzer R. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci. 2008;28:2499–2510. [PubMed]
  • Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res. 2000;122:81–103. [PubMed]
  • LeMay LG, Vander AJ, Kluger MJ. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav. 1990;47:957–961. [PubMed]
  • Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012;36:764–785. [PubMed]
  • Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999;45:833–839. [PubMed]
  • Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995;34:301–309. [PubMed]
  • Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998;10:313–318. [PubMed]
  • Maes M, Twisk FN, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom. 2012;81:286–295. [PubMed]
  • Martinez JM, Garakani A, Yehuda R, Gorman JM. Proinflammatory and "resiliency" proteins in the CSF of patients with major depression. Depress Anxiety. 2012;29:32–38. [PubMed]
  • Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci. 2001;24:1161–1192. [PubMed]
  • Meinlschmidt G, Heim C. Sensitivity to intranasal oxytocin in adult men with early parental separation. Biol Psychiatry. 2007;61:1109–1111. [PubMed]
  • Moran-Santa Maria MM, McRae-Clark AL, Back SE, DeSantis SM, Baker NL, Spratt EG, Simpson AN, Brady KT. Influence of cocaine dependence and early life stress on pituitary-adrenal axis responses to CRH and the Trier social stressor. Psychoneuroendocrinology. 2010;35:1492–1500. [PMC free article] [PubMed]
  • Mullen PE, Martin JL, Anderson JC, Romans SE, Herbison GP. The long-term impact of the physical, emotional, and sexual abuse of children: a community study. Child Abuse Negl. 1996;20:7–21. [PubMed]
  • Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci. 1998;18:2239–2246. [PubMed]
  • Odeh M. Tumor necrosis factor-alpha as a myocardial depressant substance. Int J Cardiol. 1993;42:231–238. [PubMed]
  • Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008;118:560–570. [PMC free article] [PubMed]
  • Porterfield VM, Gabella KM, Simmons MA, Johnson JD. Repeated stressor exposure regionally enhances beta-adrenergic receptor-mediated brain IL-1beta production. Brain Behav Immun. 2012;26:1249–1255. [PubMed]
  • Saxne T, Palladino MA, Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 1988;31:1041–1045. [PubMed]
  • Shin LM, Wright CI, Cannistraro PA, Wedig MM, McMullin K, Martis B, Macklin ML, Lasko NB, Cavanagh SR, Krangel TS, Orr SP, Pitman RK, Whalen PJ, Rauch SL. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry. 2005;62:273–281. [PubMed]
  • Slopen N, Lewis TT, Gruenewald TL, Mujahid MS, Ryff CD, Albert MA, Williams DR. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 2010;72:694–701. [PMC free article] [PubMed]
  • Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Res. 1996;64:161–167. [PubMed]
  • Spitzer C, Barnow S, Volzke H, Wallaschofski H, John U, Freyberger HJ, Lowe B, Grabe HJ. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J Psychiatr Res. 2010;44:15–21. [PubMed]
  • Spivak B, Shohat B, Mester R, Avraham S, Gil-Ad I, Bleich A, Valevski A, Weizman A. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry. 1997;42:345–348. [PubMed]
  • Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21:901–912. [PubMed]
  • Straub RH. Bottom-up and top-down signaling of IL-6 with and without habituation? Brain Behav Immun. 2006;20:37–39. [PubMed]
  • Taylor SE, Lehman BJ, Kiefe CI, Seeman TE. Relationship of early life stress and psychological functioning to adult C-reactive protein in the coronary artery risk development in young adults study. Biological Psychiatry. 2006;60:819–824. [PubMed]
  • Tilleux S, Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res. 2007;85:2059–2070. [PubMed]
  • Viviani B, Gardoni F, Bartesaghi S, Corsini E, Facchi A, Galli CL, Di Luca M, Marinovich M. Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem. 2006;281:30212–30222. [PubMed]
  • von Kanel R, Kudielka BM, Preckel D, Hanebuth D, Fischer JE. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav Immun. 2006;20:40–48. [PubMed]
  • Waldrop AE, Price KL, Desantis SM, Simpson AN, Back SE, McRae AL, Spratt EG, Kreek MJ, Brady KT. Community-dwelling cocaine-dependent men and women respond differently to social stressors versus cocaine cues. Psychoneuroendocrinology. 2010;35:798–806. [PMC free article] [PubMed]
  • Wang Y, Cao M, Liu A, Liu W, Zhao F, Tian Y, Jia J. Changes of inflammatory cytokines and neurotrophins emphasized their roles in hypoxic-ischemic brain damage. Int J Neurosci. 2012 [PubMed]
  • Widom CS. Posttraumatic stress disorder in abused and neglected children grown up. Am J Psychiatry. 1999;156:1223–1229. [PubMed]
  • Wu TH, Lin CH. IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav Brain Res. 2008;193:183–191. [PubMed]
  • Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994;643:40–49. [PubMed]
  • Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993;133:2523–2530. [PubMed]
  • Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA. 2001;286:1621–1627. [PubMed]
  • Zou JY, Crews FT. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 2005;1034:11–24. [PubMed]